Clinical trials
Phase 3 Bronchiectasis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 3 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 2 |
| Gilead Sciences | 2 |
| Aradigm Corporation | 1 |
| Boehringer Ingelheim | 1 |
| Mannkind Corporation | 1 |
| Neovii Biotech | 1 |
| RedHill Biopharma Limited | 1 |
| Syntara | 1 |
| Zambon SpA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bronchiectasis | 11 |
| Lung Diseases | 2 |
| Actinomycetales Infections | 1 |
| Bacterial Infections | 1 |
| Bacterial Infections and Mycoses | 1 |
| Cystic Fibrosis | 1 |
| Gram-Positive Bacterial Infections | 1 |
| Idiopathic Pulmonary Fibrosis | 1 |
| Infections | 1 |
| Mycobacterium Infections | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.